These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21236314)

  • 21. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
    Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J
    Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau imaging with [
    Ishiki A; Harada R; Okamura N; Tomita N; Rowe CC; Villemagne VL; Yanai K; Kudo Y; Arai H; Furumoto S; Tashiro M; Furukawa K
    Eur J Neurol; 2017 Jan; 24(1):130-136. PubMed ID: 27797445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modified tau is present in younger nondemented persons: a study of subcortical nuclei in Alzheimer's disease and progressive supranuclear palsy.
    Shin RW; Kitamoto T; Tateishi J
    Acta Neuropathol; 1991; 81(5):517-23. PubMed ID: 1713394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.
    Ishizawa K; Dickson DW
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):647-57. PubMed ID: 11398841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer Disease.
    Park HJ; Lee KW; Oh S; Yan R; Zhang J; Beach TG; Adler CH; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    J Neuropathol Exp Neurol; 2018 Feb; 77(2):139-148. PubMed ID: 29281045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
    Malarte ML; Gillberg PG; Kumar A; Bogdanovic N; Lemoine L; Nordberg A
    Mol Psychiatry; 2023 Mar; 28(3):1272-1283. PubMed ID: 36447011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Brainstem Tau Cytoskeletal Pathology of Alzheimer's Disease: A Brief Historical Overview and Description of its Anatomical Distribution Pattern, Evolutional Features, Pathogenetic and Clinical Relevance.
    Rüb U; Stratmann K; Heinsen H; Turco DD; Seidel K; Dunnen Wd; Korf HW
    Curr Alzheimer Res; 2016; 13(10):1178-97. PubMed ID: 27264543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive supranuclear palsy with dementia: cortical pathology.
    Bigio EH; Brown DF; White CL
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):359-64. PubMed ID: 10218631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathology of variants of progressive supranuclear palsy.
    Dickson DW; Ahmed Z; Algom AA; Tsuboi Y; Josephs KA
    Curr Opin Neurol; 2010 Aug; 23(4):394-400. PubMed ID: 20610990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The MAPT gene is differentially methylated in the progressive supranuclear palsy brain.
    Huin V; Deramecourt V; Caparros-Lefebvre D; Maurage CA; Duyckaerts C; Kovari E; Pasquier F; Buée-Scherrer V; Labreuche J; Behal H; Buée L; Dhaenens CM; Sablonnière B
    Mov Disord; 2016 Dec; 31(12):1883-1890. PubMed ID: 27709663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
    Uchihara T; Hara M; Nakamura A; Hirokawa K
    Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation and cleavage of tau in non-AD tauopathies.
    Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI
    Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration.
    Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI
    J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.